The Cigna Group (NYSE:CI) Position Boosted by Catalyst Financial Partners LLC

Catalyst Financial Partners LLC grew its holdings in shares of The Cigna Group (NYSE:CI) by 16.9% in the second quarter, according to its most recent filing with the SEC. The firm owned 927 shares of the health services provider’s stock after acquiring an additional 134 shares during the quarter. Catalyst Financial Partners LLC’s holdings in The Cigna Group were worth $306,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Silicon Valley Capital Partners boosted its stake in The Cigna Group by 100.0% during the 1st quarter. Silicon Valley Capital Partners now owns 70 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 35 shares in the last quarter. Cedar Wealth Management LLC bought a new stake in The Cigna Group in the first quarter worth about $29,000. Raleigh Capital Management Inc. lifted its holdings in The Cigna Group by 69.5% in the 4th quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 41 shares during the last quarter. TruNorth Capital Management LLC bought a new stake in shares of The Cigna Group in the 2nd quarter worth approximately $33,000. Finally, Pineridge Advisors LLC acquired a new stake in The Cigna Group during the fourth quarter valued at approximately $37,000. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In other The Cigna Group news, Director Elder Granger sold 1,000 shares of the stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $338.08, for a total transaction of $338,080.00. Following the completion of the transaction, the director now owns 5,471 shares in the company, valued at approximately $1,849,635.68. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, insider Brian C. Evanko sold 4,795 shares of the firm’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the completion of the transaction, the insider now owns 39,923 shares in the company, valued at approximately $13,773,834.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elder Granger sold 1,000 shares of the company’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $338.08, for a total value of $338,080.00. Following the sale, the director now owns 5,471 shares in the company, valued at approximately $1,849,635.68. The disclosure for this sale can be found here. Insiders sold 9,033 shares of company stock valued at $3,095,820 in the last quarter. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on CI. Baird R W raised The Cigna Group to a “strong-buy” rating in a research note on Thursday, May 30th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, August 2nd. Piper Sandler began coverage on shares of The Cigna Group in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 target price on the stock. Oppenheimer lifted their price objective on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research note on Monday, August 19th. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $384.86.

The Cigna Group Trading Down 0.2 %

CI traded down $0.77 during trading on Monday, reaching $353.22. 254,559 shares of the company’s stock were exchanged, compared to its average volume of 1,536,182. The company’s fifty day moving average price is $336.09 and its 200-day moving average price is $342.17. The firm has a market capitalization of $100.34 billion, a PE ratio of 29.06, a P/E/G ratio of 1.02 and a beta of 0.52. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $365.71. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 0.71.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 EPS for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The business had revenue of $60.52 billion during the quarter, compared to the consensus estimate of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm’s revenue was up 24.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.13 earnings per share. As a group, equities analysts forecast that The Cigna Group will post 28.4 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 19th. Stockholders of record on Wednesday, September 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Wednesday, September 4th. The Cigna Group’s dividend payout ratio (DPR) is 45.98%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.